Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression

International Immunopharmacology (2017) - Comments
pubmed: 27912149 doi: 10.1016/j.intimp.2016.11.028 issn: 1567-5769 issn: 1878-1705

Quanfang Huang, Facheng Bai, Jinlan Nie, Shengjuan Lu, Chunyuang Lu, Xunshuai Zhu, Lang Zhuo, Xing Lin